Abstract
The combination of increased CSF protein concentration and normal cell count was used by Guillain et al. (1916) as a distinguishing feature of the two cases in their original description. This combination remains the most helpful laboratory guide to the diagnosis of GBS but is not an invariable feature. In large series this “albuminocytological dissociation” is reported in about 80%–90% of patients. For instance, in a prospective study of 100 cases in south east England CSF total protein concentrations were abnormal in 80%; the mean concentration was 1.2 g/1 and range 0.1–6.0 g/1. The CSF white cell count was normal in 90%: those patients having a pleocytosis had very few cells, median 8 per µl and range 6–103 per µl (Winer et al. 1988d). Single observations on individual patients suggest that the CSF protein concentration commonly remains normal during the first ten days of the illness, increases as the disease progresses, continues to rise during the plateau and early recovery phases and eventually returns to normal (Wiederholt et al. 1964). This time course was confirmed by serial lumbar punctures in a typical case (Link 1975). No clinical differences have been discovered between those patients with persistently normal CSF protein concentrations and those exhibiting the classical albuminocytological dissociation, although differences, especially in outcome, have been sought in almost every published series.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarli JA, Aparicio SR, Lumsden CE, Tonder O (1975) Binding of normal human IgG to myelin sheaths, glia and neurons. Immunology 28: 171–185
Abbas DH, Schlagenhauff RE, Strong HE (1977) Polyradiculoneuropathy in Addison’s disease. Neurology 27: 494–495
Abramsky O, Webb C, Teitelbaum D, Arnon R (1975) Cell mediated immunity to neural antigens in idiopathic polyneuritis and myeloradiculitis. Neurology 25: 1154–1159
Abramsky O, Korn-Lubetzky I, Teitelbaum D (1980) Association of autoimmune diseases and cellular immune response to the neuritogenic protein in Guillain-Barré syndrome. Ann Neurol 8: 117
Adams D, Gibson JD, Thomas PK et al. (1977) HLA antigens in Guillain-Barré syndrome. Lancet 11: 504–505
Ala FA, Shearman DSC (1965) A case of autoimmune hemolytic anaemia, thrombocytopenia, and the Guillain-Barré syndrome. Acta Haematol (Basel) 34: 319–369
Amarenco P, Sauron B, Schuller E, Chain F, Castaigne P (1987) Serum and CSF humoral immunity in Guillain-Barré syndrome: clinical correlations. J Neurol Sci 80: 129–142
Arnason BGW, Winkler GF, Hadler NM (1969) Cell-mediated demyelination of peripheral nerve in tissue culture. Lab Invest 21: 1–10
Behan PO, Lamarche JB, Feldman RG, Sheremata WA (1970) Lymphocyte transformation in the Guillain-Barré syndrome Lancet 1: 421
Behan PO, Behan WMH, Feldman RG, Kies MW (1972) Cell mediated hypersensitivity to neural antigens. Occurrence in human patients and non-human primates with neurological diseases. Arch Neurol 27: 145–152
Behan PO, Lessels S, Roche M (1976) Optic neuritis in the Landry-Guillain-Barré-Strohl syndrome. J Ophthal 60: 58–59
Behar R, Penny R, Powell HC (1986) Guillain-Barré syndrome associated with Hashimoto’s thyroiditis. J Neurol 233: 233–236
Bertinelli A, Giani M, Rossi L et al. (1989) Ex novo cases of acute glomerulonephritis and Guillain-Barré syndrome: a case report. Clin Nephrol 31: 269–273
Best PV (1985) Acute polyradiculoneuritis associated with demyelinated plaques in the central nervous system: report of a case. Acta Neuropathol 67: 230–234
Birnbaum G (1973) Guillain-Barré syndrome. Increased lymphoproliferative potential. Arch Neurol 28: 215–218
Bornstein MB, Appel SH (1961) The application of tissue culture to the study of EAE: I. Patterns of demyelination. J Neuropathol Exp Neurol 20: 141–157
Bourouresque G, Delpuech F, Giudicelli R et al. (1981) Polyradiculoneuritis and myasthenia gravis. Nouv Presse Méd 10: 253–254
Bradbury K, Aparicio SR, Sumner DW et al. (1985) Comparison of in vitro demyelination and cytotoxicity of humoral factors in MS and other neurological diseases. J Neurol Sci 70: 167–181
Bradford JB, Bashford EF, Wilson JA (1918) Acute infective polyneuritis. Q J Med 12: 88–126
Brock S, Davidson C (1947) Fatal cryptogenic neuropathy. Arch Neurol Psychiatry 58: 559–569
Brown MJ, Rosen JL, Lisak RP (1987) Demyelination in vitro by Guillain-Barré syndrome and other human serum. Muscle Nerve 10: 263–271
Caspary EA, Currie S, Walton JN, Field EJ (1971) Lymphocyte sensitisation to nervous tissues and muscle in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 34: 179–181
Castaigne P, Berthaux P, Brunet P (1972) Polyradiculonévrites inflammatoires et immunité cellulaire: étude de la réponse immunitaire cellulaire envers des antigènes de nerf périphérique par le test de migration des leucocytes. Nouv Presse Méd 1: 2445–2449
Colaco CB, Scadding GK, Newsom Davis J (1984) Anticardiolipin antibodies in neurological diseases. Lancet 1: 164
Cook SD, Dowling PC (1981) The role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome. Ann Neurol 9 supp1: 70–79
Cook SD, Dowling PC, Whitaker JN (1970) Serum immunoglobulins in the Guillain-Barré syndrome. Neurology 20: 403
Cook SD, Dowling PC, Murray MR, Whittaker JN (1971) Circulating demyelinating factors in acute idiopathic polyneuropathy. Arch Neurol 24: 136–144
Cornblath DR, Griffin JW, Tennekoon GI (1986) Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies. Ann Neurol 20: 370–372
Cornblath DR, Griffin DE, Welch D, Griffin JW, McArthur JC (1990) Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J Neuroimmunol 26: 113–118
Corston RN (1980) Temporal arteritis in association with Guillain-Barré syndrome. Br Med J 280: 292–293
Corston RN, McGale EHF, Stonier C, Aber GM, Hutchinson EC (1981) Abnormalities of CSF amino acids in patients with the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 44: 86–89
Cruz M, Ernerudh J, Olsson T, Hoseberg B, Link H (1987) Occurrence and isotype of antibodies against peripheral nerve myelin in serum from patients with peripheral neuropathy and healthy controls. J Neurol Neurosurg Psychiatry 51: 820–825
Currie S, Knowles M (1971) Lymphocyte transformation in the Guillain-Barré syndrome. Brain 94: 109–116
Cuttner J, Meyer R (1978) Guillain-Barré syndrome in a patient with Hodgkin’s disease. Mt Sinai J Med (NY) 45: 415–417
Drachman DA, Paterson PY, Berlin B, Rogusa J (1970) Immunosuppression and Guillain-Barré syndrome. Neurology 20: 390
Dubois-Dalcq M, Buyse M, Buyse G, Gorce F (1971) The action of Guillain-Barré serum on myelin. A tissue culture and electron microscope analysis. J Neurol Sci 13: 67–83
Dummolard A, Sarrouy J, Schonshoe R, Baredoux N (1937) Polyradiculonévrite avec hyperalbuminose du liquide cephalorachidien sans réaction cellulaire et névrite optique-evolution rapide, vers le guérison ( Guillain-Barré ). Rev Oto-Neuro-Ophthalmol (Paris) 15: 26–28
Eustis-Turf EP, Benjamins JA, Lefford JL (1986) Characterization of the anti-neural antibodies in the sera of leprosy patients. J Neuroimmunol 10: 313–330
Feasby TE, Hahn AF, Gilbert JJ (1982) Passive transfer studies in Guillain-Barré polyneuropathy. Neurology 32: 1159–1167
Forrester C, Lascelles RG (1979) Association between polyneuritis and multiple sclerosis. J Neurol Neurosurg Psychiatry 42: 864–866
Frampton G, Winer JB, Cameron JS, Hughes RAC (1988) Severe Guillain-Barré syndrome: an association with IgA anti-cardiolipin antibody in a series of 92 patients. J Neuroimmunol 19: 133–139
Froelich CJ, Searles RP, Davis LE, Goodwin JS (1980) A case of Guillain Barré syndrome with immunologic abnormalities. Ann Int Med 93: 563–565
Geczy C, Raper R, Roberts IM, Meyer P, Bernard CCA (1985) Macrophage procoagulant activity as a measure of cell-mediated immunity to P2 protein of peripheral nerves in the Guillain-Barré syndrome. J Neuroimmunol 9: 179–191
Gorodezky C, Varela B, Castro-Escobar LE, Chavez-Negrete A, Escobar-Gutierrez A, Martinez-Mata J (1983) HLA-DR antigens in Mexican patients with Guillain-Barré syndrome. J Neuroimmunol 4: 1–7
Goust JM, Chenais F, Carnes JE, Hames CG, Fudenberg HH, Hogan EL (1978) Abnormal T-cell populations and circulating immune complexes in the Guillain-Barré syndrome and MS. Neurology 28: 421–428
Grant H, Leopold HN (1954) Guillain-Barré syndrome occurring during cortisone therapy. JAMA 155: 252–253
Gross PT (1980) Acute idiopathic polyneuritis and idiopathic thrombocytopenic purpura. JAMA 243: 256–257
Guilbert L, Dighiero G, Avramea S (1984) Naturally occurring antibodies against urine common antigens in neural humans. I. Detection, isolation and characterization. J Immuno 1128: 2779–2787
Guillain G, Barré JA, Strohl A (1916) Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide cephalo-rachidien sans réaction cellulaire. Remarques sur les caractères cliniques et graphiques des reflexes tendineux. Bull Soc Méd Hôp Paris 40: 1462–1470
Harris EN, Engelert H, Derve G, Hughes GRV, Gharavi A (1983) Antiphospholipid antibodies in acute Guillain-Barré syndrome. Lancet 11: 1361–1362
Harrison BM, Hansen LA, Pollard JD, McLeod JG (1984) Demyelination induced by serum from patients with Guillain-Barré syndrome. Ann Neurol 15: 163–170
Hartung H-P, Schwenke C, Bitter-Suermann D, Toyka KV (1987) Guillain-Barré syndrome: activated complement components C3a and C5a in CSF. Neurology 37: 1006–1009
Hartung H-P, Hughes RAC, Taylor WA, Heininger K, Reiners K, Toyka KV (1990) T cell activation in the Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors. Neurology 40: 215–219
Hemachudha T, Griffin DE, Giffels JJ, Johnson RT, Moser AB, Phanupak P (1987a) Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med 316: 369–374
Hemachudha T, Phanuphak P, Johnson RT, Griffin DE, Ratanvongsiri J, Siripramsomsup W (1987b) Neurologic complications of semple-type rabies vaccine: clinical and immunologic studies. Neurology 37: 550–556
Hemachudha T, Griffin DE, Chen WW, Johnson RT (1988) Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome. Neurology 38: 375–378
Hirano A, Cook SD, Whitaker JN, Dowling PC, Murray MR (1971) Fine structural aspects of demyelination in vitro the effects of Guillain-Barré serum. J Neuropathol Exp Neurol 30: 249–265
Hughes RAC (1979) Acute inflammatory polyneuropathy. In: Rose FC (ed) Clinical neuroimmunology. Blackwell, Oxford, pp 170–184
Hughes RAC, Cameron JS, Hall SM, Heaton J, Payan JA, Teoh R (1982) Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus -nerve biopsy and response to plasma exchange. J Neurol 228: 239–247
Hughes RAC, Asian S, Gray IA (1983) Lymphocyte subpopulations and suppressor cell activity in acute polyradiculoneuritis ( Guillain-Barré syndrome ). Clin Exp Immunol 51: 448–454
Hughes RAC, Gray IA, Gregson NA et al. (1984) Immune responses to myelin antigens in Guillain-Barré syndrome. J Neuroimmunol 6: 303–312
Ilyas AA, Willison HS, Quarles RH, Jungalwala KB, Cornblath DR (1988) Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol 23: 440–447
Julien J, Vital CL, Aupy G, Laugueny A, Darriet D, Brechenmacher C (1980) Guillain-Barré syndrome and Hodgkin’s disease–ultrastructural study of a peripheral nerve. J Neurol Sci 45: 23–27
Kaslow RA, Sullivan-Bolyai JZ, Hafkin B et al. (1984) HLA antigens in Guillain-Barré syndrome. Neurology 34: 240–242
Kennett RP, Morgan SH, Dudley C, Mackworth-Young C, Hull R, Hughes GR (1986) Acute polyradiculoneuropathy complicating systemic lupus erythematosus. Postgrad Med J 62: 291–294
Khoury EL, Ritacco V, Cossio PM et al. (1979) Circulating antibodies to peripheral nerve in American trypanosomiasis ( Chagas disease ). Clin Exp Immunol 36: 8–15
Klingon GH (1965) The Guillain-Barré syndrome associated with cancer. Cancer 18: 157–163
Korn-Lubetzki I, Abramsky O (1986) Acute and chronic demyelinating inflammatory polyradiculoneuropathy. Arch Neurol 43: 604–608
Koski CL, Humphrey R, Shin ML (1985) Anti-peripheral myelin antibodies in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibodies by complement component transfer and fixation. Proc Natl Acad Sci USA 82: 905–909
Koski CL, Gratz E, Sutherland J, Mayer RF (1986) Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome. Ann Neurol 19: 573–577
Koski CL, Sanders ME, Swoveland PT et al. (1987) Activation of terminal components of complement on patients with Guillain-Barré syndrome and other demyelinating neuropathies. J Clin Invest 80: 1492–1497
Koski CL, Chou DKH, Jungalwala FB (1989) Anti-peripheral nerve myelin antibodies in Guillain-Barré syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen. J Clin Invest 84: 280–287
Kruger H, Englert D, Pfughaupt KW (1981) Demonstration of oligoclonal immunoglobulin G in Guillain-Barré syndrome and lymphocytic meningoradiculitis by isoelectric focusing. J Neurol 226: 15–24
Lassmann H, Budka H, Schnaberth G (1981) Inflammatory demyelinating polyradiculitis in a patient with multiple sclerosis. Arch Neurol 38: 99–102
Latov N, Gross RB, Kastelman J et al. (1981) Complement fixing antiperipheral nerve myelin antibodies in patients with inflammatory polyneuritis and with polyneuropathy and paraproteinemia. Neurology 31: 1530–1534
Link H (1975) Demonstration of oligoclonal immunoglobulin in Guillain-Barré syndrome. Acta Neurol Scand 52: 111–120
Link H, Wahren B, Norrby E (1979) Pleocytosis and immunoglobulin changes in CSF and herpes virus serology in patients with Guillain-Barré syndrome. J Clin Microbiol 9: 305–316
Lisak RP, Zweiman B, Norman M (1975) Antimyelin antibodies in neurologic diseases: immunofluorescent demonstration. Arch Neurol 32: 163–167
Lisak RP, Mitchell M, Zweiman B, Orrechio E, Asbury AK (1977) Guillain-Barré syndrome and Hodgkin’s disease: three cases with immunological studies. Ann Neurol 1: 72–78
Lisak RP, Kuchmy D, Armati-Gulson PJ, Brown MJ, Sumner AJ (1984) Serum mediated Schwann cell cytotoxicity in the Guillain-Barré syndrome. Neurology 34: 1240–1243
Lisak RP, Zweiman B, Guerrero F, Moskovitz AR (1985) Circulating T cell subsets in Guillain Barré syndrome. J Neuroimmunol 8: 93–101
Livrea P, Zimatore GB, Simone IL et al. (1980) Isoelectric focusing and quantitative estimation of cerebrospinal fluid and serum IgG in idiopathic polyneuropathy. J Neurol 223: 1–12
Low PA, Schmelzer J, Dyck PJ, Kelly JJ (1982) Endoneurial effects of sera from patients with acute inflammatory polyradiculoneuropathy: electrophysiological studies on normal and demyelinated rat nerves. Neurology 32: 720–724
Luijten JAFM, De Jong WAC, Demel RA, Heijnen CJ, Ballieux RE (1985) Peripheral nerve P2 basic protein and the Guillain-Barré syndrome. In vitro demonstration of P2-specific antibody secreting cells. J Neurol Sci 66: 209–216
MacGregor GA (1965) Familial Guillain-Barré syndrome. Lancet 11: 1296
Mactier RA, Khanna R (1987) Guillain-Barré syndrome in kappa light chain myeloma. South Med J 80: 1054–1055
Martin JJ (1961) Polyradiculonévrite avec dissociation albuminocytologique (du type Guillain Barré) et atteinte optique (contribution anatomo-clinique). Psychiatry Neurol 142: 265–292
McCombe PA, Clarke P, Frith JA et al. (1985) Alpha-1 antitrypsin phenotypes in demyelinating disease: an association between demyelinating disease and the allele PiM3. Ann Neurol 18: 514–516
Mead GM, Cowin P, Whitehouse IMA (1980) Antitubulin antibody in healthy adults and patients with infectious mononucleosis and its relationship to smooth muscle antibody. Clin Exp Immunol 39: 228–336
Melnick SC (1963) Bcases of the Guillain-Barré syndrome; an immunological study. Br Med J 1:368–373
Moreila Filho PF, Cini Cinatus D, Freitas MRG, Nascimento JM, Porto FJS, Santos PC (1980) Guillain-Barré syndrome as a manifestation of SLE. Arq Neuropsiquiatr 38: 165–170
Mouren P, Vital-Bernard P, Poinso Y et al. (1971) Névrite optique retrobulbaire au cours d’un syndrome de Guillain-Barré. Rev Oto-Neuro-Ophtalmol (Paris) 43: 216–221
Murphy BF, Gonzales MF, Ebeling P, Fairley KF, Kincaid-Smith P (1986) Membranous glomerulonephritis and Landry—Guillain-Barré syndrome. Am J Kidney Dis 8: 267–270
Nikoskelainen E, Riekkinen P (1972) Retrobulbar neuritis as an early symptom of Guillain-Barré syndrome: report of a case. Acta Opthalmol (Copenh) 50: 111–115
Nyland H, Aarli JA (1978) Guillain-Barré syndrome; demonstration of antibodies to peripheral nerve tissue. Acta Neurol Scand 58: 35–43
Nyland H, Naess A (1978) Lymphocyte subpopulations in blood and cerebrospinal fluid from patients with acute Guillain-Barré syndrome. Eur Neurol 17: 247–252
Okuyama H (1975) Mechanism of increase of the cerebrospinal fluid (CSF) protein content in Guillain-Barré syndrome. Clin Neurol (Tokyo) 15: 817–826
Osterman PO, Vedeler CA, Ryberg B, Fagius J, Nyland H (1988) Serum antibodies to peripheral nerve tissue in acute Guillain-Barré syndrome in relation to outcome of plasma exchange. J Neurol 233: 285–289
Palosuo T, Vaarala O, Kinnunen E (1985) Cardiolipin antibodies in Guillain-Barré syndrome. Lancet 11: 839
Potz G, Neundorfer B (1975) Polyradiculoneuritis and Hashimoto’s thyroiditis. J Neurol 210: 283–289
Pradalier A, Gettler V, Feyeux C, Dry J (1982) Guillain-Barré polyradiculopathy and segmental colitis. Nouv Presse Méd 11: 35–73
Rocklin RE, Sheremata WA, Feldman RG, Kies MW, David JR (1971) Cellular response in Guillain-Barré syndrome and multiple sclerosis. N Engl J Med 284: 803–808
Rodriguez-Iturbe B, Garcia R, Rubio L, Zabala J, Maros G, Torres R (1973) Acute glomerulonephritis in the Guillain-Barré—Strohl syndrome. Report of 9 cases. Ann Intern Med 78: 391–395
Rosenberg RN, Aung MH, Tindall RSA (1975) Idiopathic polyneuropathy associated with cytotoxic anti-neuroblastoma serum: IgG and IgM immunoglobulin studies. Neurology 25: 1101–1110
Rostami AM, Burns JB, Eccleston PA, Manning MC, Lisak RP, Silberberg DH (1987) Search for antibodies to galactocerebroside in the serum and CSF in human demyelinating disorders. Ann Neurol 22: 381–382
Rozen D, VanHaeverbeek M, Stenuit R, Ardichvili D (1980) Polyradiculitis, B. fragilis septicemia, peritonitis in a patient with SLE. Rev Méd Brux 1: 395–398
Ryberg B (1984) Extra and intrathecal production of antinerve and antibrain antibodies in Guillain-Barré syndrome: evaluation by an antibody index. Neurology 34: 1378–1381
Sabin AB, Aring CD (1941) Visceral lesions in infectious polyneuritis. Am J Pathol 17: 469–481
Sadovnick AD, Paty DW, Yannakoulias G (1989) Concurrence of multiple sclerosis and inflammatory bowel disease. N Engl J Med 321: 762–763
Saida T, Saida K, Lisak RP, Brown MJ, Silberberg DH, Asbury AK (1982) in vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann Neurol 11: 69–75
Sanders EACM, Lee KD (1987) Acute Guillain-Barré syndrome in multiple sclerosis, J Neurol 234: 128
Sanders EACM, Yewdall VMA, Hughes RAC, Cameron JS (1988) Absence of complement activation in demyelinating polyradiculoneuropathies. Ann Neurol 23: 102–103
Sanders ME, Koski CL, Robbins D (1986) Activated terminal complement in CSF in Guillain-Barré syndrome and multiple sclerosis. J Immunol 136: 4456–4459
Saunders M, Rake M (1965) Familial Guillain-Barré syndrome. Lancet 11: 1106–1107
Seares RP, Davis LE, Hermanson S (1981) Lymphocytotoxic antibodies in Guillain-Barré syndrome. Lancet 1: 273
Segurado OG, Kruger H, Mertens HG (1986) Clinical significance of serum and CSF findings in the Guillain-Barré syndrome and related disorders. J Neurol 233: 202–208
Seil Fir (1977) Tissue culture studies of demyelinating disease: a critical review. Ann Neurol 2: 345–355
Sheremata WA, Colby S, Karkhanis Y, Eylar E (1975) Cellular hypersensitivity to basic myelin ( P2) protein in the Guillain-Barré syndrome. Can J Neurol Sci 2: 87–90
Siddiqui B, Haromori S-I (1971) A revised structure for the Forssman glycolipid hapten. J Biol Chem 246: 5766
Smith KJ Hall SM (1988) Peripheral demyelination and remyelination initiated by the calciumselective ionophore ionomycin: in vivo observations. J Neurol Sci 83: 37–53
Spaar FW, Orthner H (1968) Adrenalitis inclusio necroticans in the Landry-Guillain-Barré syndrome. Dtsch Z Nervenheilkd 193: 195–213
Stefansson K, Marton LS, Dieperink ME, Molinar GK, Schlaepfer WW, Helgason CM (1985) Circulating autoantibodies to the 200 000 dalton protein of neurofilaments in the serum of healthy individuals. Science 228: 1117–1119
Steiner I, Wirguin I, Abramsky O (1986) Appearance of Guillain-Barré syndrome in patients during corticosteroid treatment. J Neurol 233: 221–223
Stewart GJ, Pollard JD, McLeod JG, Wolnizer CM (1978) HLA antigens in the Landry—GuillainBarré syndrome and chronic relapsing polyneuritis. Ann Neurol 4: 285–289
Sumner AJ, Saida K, Saida T, Silberberg DH, Asbury AK (1982) Acute conduction block associated with experimental antiserum mediated demyelination of peripheral nerve. Ann Neurol 11: 469–477
Tachovsky T, Lisak RP, Koprowski H (1976) Circulating immune complexes in multiple sclerosis and other neurological disorders. Lancet 11: 997–999
Taylor WA, Hughes RAC (1989) T lymphocyte activation antigens in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J Neuroimmunol 24: 33–39
Toh BH, Yildiz A, Sotelo J, Holborow EJ, Kanankoundi F (1979) Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments. Clin Exp Immunol 37: 76–82
Tonnessen TI, Nyland H, Aarli JA (1982) Complement factors and acute phase reactants in the Guillain-Barré syndrome. Eur Neurol 21: 125–128
Tse KS, Arbesman CE, Tomasi TB, Tourville D (1971) Demonstration of antimyelin antibodies by immunofluorescence in Guillain-Barré syndrome. Clin Exp Immunol 8: 881–887
Uncini A, Treviso M, Basciani M, Onofrj M, Gambi D (1988) Associated central and peripheral demyelination: an electrophysiological study. J Neurol 235: 238–240
van Doom PA, Brand A, Vermeulen M (1987) Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy. Neurology 37: 1798–1802
Vedeler CA, Nyland H, Matre R (1982) Antibodies to peripheral nerve tissue in sera from patients with acute Guillain-Barré syndrome demonstrated by mixed haemagglutination technique. J Neuroimmunol 2: 209–214
Wiederholt HM, Mulder DW, Lambert EH (1964) The Landry Guillain-Barré-Strohl syndrome of polyradiculoneuropathy — historical review: report on 97 patients and present concepts. Mayo Clin Proc 49: 427–451
Winer JB, Gray IA, Gregson NA et al. (1988a) A prospective study of acute idiopathic neuropathy. III. Immunologic studies. J Neurol Neurosurg Psychiatry 51: 619–625
Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RFP (1988b) A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 51: 613–618
Winer JB, Briggs D, Welsh K, Hughes RAC (1988c) HLA antigens in the Guillain-Barré syndrome. J Neuroimmunol 18: 13–16
Winer JB, Hughes RAC, Osmond C (1988d) A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 51: 605–612
Winkler GF (1965) In vitro demyelination of peripheral nerve induced with sensitized cells. Ann NY Acad Sci 122: 287–296
Yonezawa T, Ishihara Y, Matsuyama H (1968) Studies on experimental allergic neuritis. I. Demyelinating patterns studied in vitro. J Neuropathol Exp Neurol 27: 453–463
Yonezawa T, Ishihara Y, Sato Y (1969) Demyelinating antibodies of EAE and peripheral neuritis represented by demyelinating pattern in vitro. J Neuropathol Exp Neurol 28: 180–181
Yonezawa T, Robbins N, Ishipara Y, Iwanami H, Nakatani Y (1970) In vitro demyelination produced by sera from Landry—Guillain-Barré syndrome. Proc Int Congr Neurol 6: 688–689
Zweiman B, Rostami A, Lisak RP, Moskovitz AR, Pleasure DE (1983) Immune reactions to P2 protein in human inflammatory demyelinative neuropathies. Neurology 33: 234–237
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag London Limited
About this chapter
Cite this chapter
Hughes, R.A.C. (1990). Immunology of Guillain-Barré Syndrome. In: Guillain-Barré Syndrome. Clinical Medicine and the Nervous System. Springer, London. https://doi.org/10.1007/978-1-4471-3175-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3175-5_9
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3177-9
Online ISBN: 978-1-4471-3175-5
eBook Packages: Springer Book Archive